Intelligent Bio Solutions adopts Second Amended and Restated Bylaws; majority-vote standard clarified

INTELLIGENT BIO SOLUTIONS INC.

Board adopted the Second Amended and Restated Bylaws effective October 12, 2026, revising Section 2.6 on stockholder voting.
Non-director matters now decided by affirmative vote of a majority in voting power of votes cast; abstentions and broker non-votes are excluded and have no effect.
An investor presentation was made available October 13, 2026 via the Investors section of www.ibs.inc (furnished as Exhibit 99.1).
Exhibit 99.1 text was not appended to the filing, so no presentation figures, guidance or business updates can be reported.
Signed by CFO Spiro Sakiris; common stock (INBS) trades on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.